NIH seeks input from the biomedical research community, biotechnology and pharmaceutical companies and other members of the public on interest and opportunities of engagement with the Illuminating the Druggable Genome (IDG) Program. The purpose of this Request for Information (RFI) is to identify and obtain comments on strategies for sharing potential data, tools, and other resources of common interest generated by the IDG Program and by external stakeholders to maximize the impact of the IDG Program.
Document
Request for Information on Input on Opportunities of Engagement of External Stakeholders With the “Illuminating the Druggable Genome” (IDG) Program
NIH seeks input from the biomedical research community, biotechnology and pharmaceutical companies and other members of the public on interest and opportunities of engagement wi...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 18306
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Request for Information on Input on Opportunities of Engagement of External Stakeholders With the “Illuminating the Druggable Genome” (IDG) Program,” thefederalregister.org (April 18, 2017), https://thefederalregister.org/documents/2017-07795/request-for-information-on-input-on-opportunities-of-engagement-of-external-stakeholders-with-the-illuminating-the-drugg.